Renu Goyal

Renu Goyal

Active Director Director DIN 06532843
DIN 06532843 First appointment Apr 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2013
Shareholding value •••• Premium profile

About Renu Goyal

Data last updated:

Renu Goyal is a Director at Natural Biodrugs Private Limited (since 2013). The company operates in Chemicals. Natural Biodrugs Private Limited reported revenue of ₹51,450 (FY 2024).

DIN 06532843
Primary Designation Director
Industry Chemicals
First Appointment 15 Apr 2013
Oldest Company Age 13 yrs
Largest company Natural Biodrugs Private Limited · ₹51,450 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Natural Biodrugs Private Limited U24232RJ2013PTC042114
Director15 Apr 20132013₹51,450 (FY 2024)Active

Board colleagues of Renu Goyal

NameDINCompanyDesignation
Mohit Aggarwal06532812Natural Biodrugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Natural Biodrugs Private Limited
Premium access

Shareholding and investment profile for Renu Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Goyal

Renu Goyal currently holds 1 directorship: Natural Biodrugs Private Limited (Director, since 15 Apr 2013, revenue ₹51,450 (FY 2024)).

Renu Goyal was first appointed on 15 Apr 2013 as Director at Natural Biodrugs Private Limited.

The current boards of Renu Goyal's companies include Mohit Aggarwal (Natural Biodrugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available